| Literature DB >> 30805322 |
Abstract
Kawasaki disease (KD) is a multisystem vasculitis that primarily affects the coronary arteries of young children. The causes of KD remain a mystery. It is suspected that some sort of infectious agent is involved because KD has epidemicity and seasonality. That said, the incidence of the disease is high among Japanese people, so it can be speculated that the hosts may have some sort of genetic characteristic that leaves them susceptible to KD. Various theories regarding the etiology have been asserted, such as the infectious vasculitis theory, autoantigen theory, superantigen theory, and RNA virus theory; however, none of them have been able to overcome this epidemicity. Taking into consideration the knowledge gained from previous reports, the best scenario explaining the pathogenesis is "individuals with certain genetic backgrounds are affected by microorganisms which trigger KD." In this article, the pathogenesis of KD is discussed with a focus on the microorganisms mentioned above, along with the previous and current hypotheses as well as my own opinion.Entities:
Keywords: Kawasaki disease; epidemicity; etiology; heat-shock proteins; superantigens
Year: 2019 PMID: 30805322 PMCID: PMC6371652 DOI: 10.3389/fped.2019.00018
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
Epidemiological conditions that the pathogen of Kawasaki disease must meet (8).
| Frequently observed in infants aged four or younger |
| Moderate epidemicity |
| Frequently observed in Japanese people |
| Includes six types of characteristic clinical symptoms |
| Redness in the BCG region |
| Cures within 2–3 weeks (self-limited) |
| Coronary artery lesions occur |
| Exhibits hematologically strong inflammation findings in the acute stage |
| Blood platelets increase in the convalescent stage |
| Antimicrobial agents are ineffective |
Figure 1Etiology hypotheses and mechanisms. TNF, tumor necrosis factor; IL, interleukin; VEGF, vascular endothelial growth factor; APC, antigen-presenting cells; MΦ, macrophages.
Figure 2Detection of antibodies responses to bacterial products. The target proteins could be produced in the acute phase of Kawasaki disease and neutralized by intravenous immunoglobulin in the convalescent phase.
Figure 4Affinity between HLA-DR4 and the binding site with MHC class II molecules on bacterial HSP60.